Skip to main content
CSL Limited (ASX:CSL)
Australia flag Australia · Delayed Price · Currency is AUD
146.27
-0.22 (-0.15%)
At close: Mar 6, 2026

CSL Limited Revenue

CSL Limited had revenue of $8.33B USD in the half year ending December 31, 2025, with 3.46% growth. This brings the company's revenue in the last twelve months to $15.41B, up 1.16% year-over-year. In the fiscal year ending June 30, 2025, CSL Limited had annual revenue of $15.56B with 5.12% growth.

Revenue (ttm)
$15.41B
Revenue Growth
+1.16%
P/S Ratio
3.05
Revenue / Employee
$515.22K
Employees
29,904
Market Cap
70.37B AUD

Revenue Chart

* This company reports financials in USD.

History

Fiscal Year End Revenue Change Growth
Jun 30, 202515.56B758.00M5.12%
Jun 30, 202414.80B1.49B11.19%
Jun 30, 202313.31B2.75B26.02%
Jun 30, 202210.56B252.00M2.44%
Jun 30, 202110.31B1.16B12.67%
Jun 30, 2020 Pro Pro Pro
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro
Jun 30, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Telix Pharmaceuticals 1.21B
Mesoblast 98.02M
Neuren Pharmaceuticals 64.65M
PYC Therapeutics 20.56M
Clarity Pharmaceuticals 10.58M
Opthea -20.12K
Immutep 7.92M
Clinuvel Pharmaceuticals 96.30M
Revenue Rankings

CSL Limited News

More News